Month: May 2020

Raison sociale de l’émetteur : NATIXIS – SA au capital de 5 049 354 392,00 eurosImmatriculée sous le n° B 542 044 524 RCS ParisSiège social : 30 avenue Pierre Mendès-France – 75013 Paris* Total net : nombre total de droits de vote attachés au nombre total d’actions – actions privées de droits de vote (auto détention …)Le capital de 5 049 354 392,00 euros a été constaté par une décision du Directeur Général du 1ER MARS 2020.Pièce jointeinfo mensuelle K+DV 2020 04 30

RENO, Nev., May 11, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) today announced financial results for the first quarter ended March 31, 2020.Financial Results“In the first quarter, we achieved strong results, driven by the solid performance of our electricity segment, which benefits from our continuous efforts to streamline operations and optimize power generation,” commented Isaac Angel, Chief Executive Officer. “Our electricity segment gross margin improved by 350 basis points excluding the contribution of insurance claims, demonstrating our improved efficiency and greater profitability at the same revenue level. The world is currently facing a global health crisis and we are experiencing a dramatic volatile economic environment, the impact and duration of which is still uncertain. In the first quarter, we took...

AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”, “Plus”), today announced the closing of its previously announced definitive agreement to license multiple rare cancer product candidates from private Texas-based radiotherapeutic company NanoTx Therapeutics, Inc.The transaction terms include an upfront payment of $400,000 in cash and $300,000 in Plus voting stock. Furthermore, the Company may pay up to $136.5 million in development and sales milestone payments and a tiered single-digit royalty on U.S. and European sales.The licensed radiotherapeutic portfolio includes nanoliposome-encapsulated radionucleotides for several cancer targets. The lead asset is a Rhenium-186-chelated NanoLiposome (RNL™), which is initially being developed for recurrent glioblastoma. RNL™ is currently...

BRIDGEWATER, N.J., May 11, 2020 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (NASDAQ: SNCR), a global leader and innovator in cloud, messaging, digital and IoT platforms and products, today announced financial results for its first quarter ended March 31, 2020.Financial quarter highlights:Revenue for the quarter was $77.1 million.GAAP net loss for the quarter was $12.0 million.Synchronoss delivered $1.8 million of adjusted EBITDA for the quarter.Total costs and expenses were down 12.9 percent in the first quarter.Synchronoss ended the quarter with $30.9 million of cash on the balance sheet.Glenn Lurie, president and chief executive officer, stated “The strong foundation of long-term recurring revenue business that we have built with blue chip customers, and the new business wins that we added to our revenue base in 2019 and...

SAN CARLOS, Calif., May 11, 2020 (GLOBE NEWSWIRE) — Check Point Research, the Threat Intelligence arm of Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, has published its latest Global Threat Index for April 2020. Researchers saw several COVID-19 related spam campaigns distributing a new variant of the Agent Tesla remote access trojan, moving it up to 3rd place in the Index, impacting 3% of organizations worldwide.The new variant of Agent Tesla has been modified to steal Wi-Fi passwords in addition to other information – such as Outlook email credentials – from target PCs. During April, Agent Tesla was distributed as an attachment in several malicious COVID-19 related spam campaigns, which attempt to lure the victim into downloading malicious files under the cover...

New Adult-Use Customers Can Only Shop Online or Over-the-Phone for In-Store PickupMedical Patients Can Shop In-Store, Online or Over-the-Phone for Convenient Curbside or In-Store PickupBOCA RATON, Fla., May 11, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCXQ: JUSHF), a globally-focused, multi-state cannabis and hemp operator, announces the beginning of adult-use sales at its dispensary in Normal, Illinois (Bloomington-Normal metropolitan area). As previously announced, Jushi’s Illinois dispensaries now operate under the Company’s BEYOND / HELLO™ brand.On Monday, May 11, 2020 at 9:00 a.m., BEYOND / HELLO™ Bloomington-Normal will begin serving adult-use customers through Jushi’s newly launched online shopping experience at www.beyond-hello.com and over-the-phone orders for in-store pickup....

DIETIKON, SWITZERLAND, May 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ For the purpose of standing out, Cannabis Suisse Corp. has announced a new retail product in the variety of the Company’s offerings. They range from helping consumers grow their own Cannabis plants to a revolutionary pure base CBD vape liquid. During the global crisis the Company is not ceasing to create and deliver innovative ideas.Since the cannabis industry has developed, the brands on the market have been working extensively on improving the production quantity and the quality of pre-rolled joints. They have become so popular among users of recreational cannabis due to their small size and compactness.It’s a rather easy-to-use product that delivers an enjoyable and unique experience anytime people use it. The consistency of the joints is simply royal which...

Spin-off of Entertainment Businesses Completed in AprilFiscal 2020 Third Quarter Marks Last Quarter of Combined Sports and Entertainment ResultsNEW YORK, May 11, 2020 (GLOBE NEWSWIRE) — Madison Square Garden Sports Corp. (NYSE: MSGS) today reported financial results for the fiscal third quarter ended March 31, 2020.  On April 17, 2020, The Madison Square Garden Company completed the spin-off of its entertainment businesses into a new company called Madison Square Garden Entertainment Corp. and changed its name to Madison Square Garden Sports Corp. (“the Company”).  As a result of the timing of the spin-off, the Company’s fiscal 2020 third quarter consolidated results include the financial results of both the sports and entertainment businesses.  Since this does not reflect the results of Madison Square Garden Sports Corp. on a standalone...

Arbutus remains on track to achieve its key 2020 objectives despite COVID-19 challengesConference Call and Webcast Scheduled Today at 8:00 AM ETWARMINSTER, Pa., May 11, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today reports its first quarter 2020 financial results, provides a pipeline update and announces the establishment of a new research initiative focused on the identification of novel therapies to combat COVID-19.William Collier, President and Chief Executive Officer of Arbutus, stated, “As we announced in March, preliminary results from an ongoing Phase 1a/1b clinical trial for our lead compound, AB-729, demonstrate that it is a potent RNAi agent capable of reducing...